Who
Thomas A. West
Director
Company insider
Files Form 4 as: Director, CeriBell; Director, Si-Bone; Director, Inogen; Director, Orthofix Medical; President and CEO, Intersect ENT; Div President & GM, Diagnostic, Hologic.
In numbers
- Trades disclosed
- 65
- Buys
- 1
- Sells
- 0
- Bought
- $161K
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 3 Oct 2014
- Last trade
- 28 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 30 Jul 2026 | CBLL CeriBellMedical Devices | SEC FORM 4 Code A | —16,011 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | CBLL CeriBellMedical Devices | SEC FORM 4 Code A | —16,011 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —10,957 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —10,957 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —8,675 at $0.00 | filing |
| 26 Jun 2024filed 27 Jun 2024 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —8,791 at $0.00 | filing |
| 26 Jun 2024filed 27 Jun 2024 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —18,315 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | INGN InogenMedical Devices | SEC FORM 4 Code A | —21,871 at $0.00 | filing |
| 31 May 2023filed 2 Jun 2023 | INGN InogenMedical Devices | SEC FORM 4 Code A | —17,094 at $0.00 | filing |
| 1 Apr 2023filed 4 Apr 2023 | INGN InogenMedical Devices | SEC FORM 4 Code A | —1,712 at $0.00 | filing |
| 31 Oct 2022filed 11 Jan 2023 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | $6,989512 at $13.65 | filing |
| 6 Jun 2022filed 8 Jun 2022 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —6,383 at $0.00 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENToption or derivative | SEC FORM 4 Code U | $2.2M78,700 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENToption or derivative | SEC FORM 4 Code U | $3.3M118,461 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENToption or derivative | SEC FORM 4 Code U | $2.8M97,960 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENToption or derivative | SEC FORM 4 Code U | $12.1M427,147 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENT | SEC FORM 4 Code U | $1.1M39,700 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENT | SEC FORM 4 Code U | $3.0M104,456 at $28.25 | filing |
| 13 May 2022filed 16 May 2022 | Intersect ENT | SEC FORM 4 Code U | $5.9M207,592 at $28.25 | filing |
| 4 Feb 2022filed 4 Feb 2022 | Intersect ENT | SEC FORM 4 Code F | $132K4,823 at $27.28 | filing |
News
No headline names them, or the companies they trade most, lately.